Skip to main content
Clinical Trials/NCT01346735
NCT01346735
Completed
Not Applicable

Multi-center Observational Study to Evaluate Epidemiology and Resistance Patterns of Common ICU-Infections (MOSER)

Indian Society of Critical Care Medicine1 site in 1 country381 target enrollmentAugust 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nosocomial Infections
Sponsor
Indian Society of Critical Care Medicine
Enrollment
381
Locations
1
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Most literature on ICU infections and the resistant patterns comes from the western literature. This data may not truly reflect the incidence, epidemiology and resistance patterns in developing countries such as India. However, empiric antibiotic therapy is generally initiated using western guidelines. This can potentially lead to inadequate, inappropriate and ineffective empiric antibiotic therapy for ICU infections in the Indian setting. Hence in this multi-center observational study, we seek to:

  1. To determine the incidence of ICU-related infections (VAP, CAUTI and CRBSI) in India
  2. To explore the microbiology, resistance and treatment patterns of these infections
Registry
clinicaltrials.gov
Start Date
August 2011
End Date
October 2012
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Ramesh Venkataraman

Dr

Indian Society of Critical Care Medicine

Eligibility Criteria

Inclusion Criteria

  • ICU stay \>48 hours
  • One of the following infections (VAP, CAUTI or CRBSI)

Exclusion Criteria

  • Index ICU stay \< 48 hours
  • Re-admissions to the ICU within the same hospitalization
  • Age \>18 years or \<70 years
  • Known HIV serology positivity
  • Solid organ or Bone-marrow transplant
  • No ICU-acquired infections (specifically VAP, CAUTI and CRBSI)

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials